Eur Rev Med Pharmacol Sci 2022; 26 (17): 6351-6360
DOI: 10.26355/eurrev_202209_29661

Current diagnosis and potential obstacles for post-neurosurgical bacterial meningitis

M.-Y. Bao, H.-T. Xie, P. Gao, X. Mao, Z.-Y. Li, W.-H. Wang, S. Sopheak, H.-W. Cheng, L. Ye, X. Zhang

Department of Neurosurgery, the First Affiliated Hospital of Anhui Medical University, Hefei, China. zxahmu1h@163.com


Despite the guidance of aseptic technology applied, bacterial meningitis seems to be an unavoidable obstacle in the process of neurosurgery, with high rates of disability and mortality. The diagnosis of post-neurosurgical bacterial meningitis (PNBM) mainly depends both on clinical symptoms and laboratory outcomes. Due to the excessive neuro-inflammatory reactions which are evoked by the primary brain disease or the craniotomy operation, the symptoms derived from the infection and aseptic may not be easily distinguished. On the other hand, the low positive rate and time-consuming character restrict the clinical practical values of bacterial culture. Therefore, it is always difficult to make a definite diagnosis of post-neurosurgical bacterial meningitis. Here, we reviewed the established literature about the diagnostic biomarkers for the PNBM and analyzed the potential obstacles in both clinical and scientific studies. Given the obstacle which has negative impacts on further investigation about the biology of PNBM, we only find relatively small numbers of study on PNBM. In this review, we summarize the established diagnostic methods and biomarkers for PNBM. Meanwhile, we also propose some potential investigation prospects. This review may help to better understand the character of PNBM in both clinical diagnosis and scientific investigations.

Free PDF Download

To cite this article

M.-Y. Bao, H.-T. Xie, P. Gao, X. Mao, Z.-Y. Li, W.-H. Wang, S. Sopheak, H.-W. Cheng, L. Ye, X. Zhang
Current diagnosis and potential obstacles for post-neurosurgical bacterial meningitis

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 17
Pages: 6351-6360
DOI: 10.26355/eurrev_202209_29661